Latest news
Debiopharm to showcase research results of their DDR Inhibitors at the 2024 AACR Conference in San Diego
Debiopharm Launches Expansion of WEE1 Inhibitor Monotherapy Research in Gynecological Cancers and Other Biomarker-Driven Solid Tumors
Strategikon Closes Series A1 Funding Round to Modernize Clinical Trials Business Operations Worldwide
Challenge pour la Qualité de vie du patient 2024, l’appel à projets est ouvert
TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer
Debiopharm and ThinkingNodeLife.ai Forge Strategic Partnership to Propel Cancer Drug Development
MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment
Debiopharm Extends SunRock Biopharma Partnership for Antibody-Drug Conjugates Targeting HER3 in EGFR Mutated Cancers
Stay informed
Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.